about
Angiotensin Converting Enzyme and Angiotensin II Type 1 Receptor Polymorphisms in Patients with Coronary AneurysmsInfluence of diabetes mellitus on heart failure risk and outcomeA common variant of endothelial nitric oxide synthase (Glu298Asp) is associated with collateral development in patients with chronic coronary occlusions.Potential of non-coding RNA as biomarkers in heart failureScreening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trialsEffect of aspirin in addition to oral anticoagulants in stable coronary artery disease outpatients with an indication for anticoagulation.Proteomic analysis in cardiovascular diseases.ACE gene polymorphism and coronary restenosis.Deep plasma proteomic analysis of patients with left ventricular remodeling after a first myocardial infarction.Strategy for purification and mass spectrometry identification of SELDI peaks corresponding to low-abundance plasma and serum proteins.Cardiovascular proteomics: translational studies to develop novel biomarkers in heart failure and left ventricular remodeling.Usefulness of circulating biomarkers for the prediction of left ventricular remodeling after myocardial infarction.Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.Multimarker proteomic profiling for the prediction of cardiovascular mortality in patients with chronic heart failureAngioplasty in the diabetic patient.Time course of increased cellular proliferation in collateral arteries after administration of vascular endothelial growth factor in a rabbit model of lower limb vascular insufficiencyPreclinical Development of a MicroRNA-Based Therapy for Elderly Patients With Myocardial Infarction.Nature of coronary disease in patients with insulin resistance and its impact on revascularization strategies.Practice Patterns for Outpatients With Stable Coronary Artery Disease: A Case Vignette-based Survey Among French CardiologistsFunctional mitral regurgitation and chronic heart failure.B-type natriuretic peptide for the prediction of left ventricular remodelling.Dosing strategies for antiplatelet therapy in percutaneous coronary intervention.High on-treatment platelet reactivity with ticagrelor versus prasugrel: a systematic review and meta-analysis.A systematic review and meta-regression of temporal trends in the excess mortality associated with diabetes mellitus after myocardial infarction.Copeptin in acute coronary syndromes and heart failure management: State of the art and future directions.Incident Myocardial Infarction and Very Late Stent Thrombosis in Outpatients With Stable Coronary Artery Disease.Evaluation of screening for myocardial ischaemia in women at cardiovascular risk.Circulating long noncoding RNA, LIPCAR, predicts survival in patients with heart failure.Long-term oral administration of L-arginine reduces intimal thickening and enhances neoendothelium-dependent acetylcholine-induced relaxation after arterial injury.Effect of left ventricular systolic dysfunction on secondary medical prevention and clinical outcome in stable coronary artery disease patients.Angiotensin II receptor blockers versus angiotensin-converting enzyme inhibitors in patients with stable coronary artery disease: Prevalence, correlates, and prognostic impact (from the CORONOR study).Clopidogrel Use as Single Antiplatelet Therapy in Outpatients with Stable Coronary Artery Disease: Prevalence, Correlates and Association with Prognosis (from the CORONOR Study).Predicting left ventricular remodeling after a first myocardial infarction by plasma proteome analysis.Gene therapy for cardiovascular diseases.Prevalence and correlates of non-optimal secondary medical prevention in patients with stable coronary artery disease.Prognostic Significance of the Renal Resistive Index After Renal Artery Revascularization in the Context of Flash Pulmonary Edema.Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo.Late recovery in left ventricular systolic function after discharge of patients with a first anterior myocardial infarction.Hybrid revascularization, comprising coronary artery bypass graft with exclusive arterial conduits followed by early drug-eluting stent implantation, in multivessel coronary artery disease.
P50
Q24800120-25F706E2-76FD-47FB-AFC5-DCB5E07FA53AQ24800363-8527851D-F2A1-4582-B920-AB0B45AF65D7Q24817217-9BBF65AF-8B74-45D3-B64C-30981792EB7DQ26784127-EB887F00-C057-489A-A906-230DD0419DCCQ28067628-FEBF3206-2069-4DD1-AF9C-3E56A83D8C50Q30390016-3E72DF63-7B43-464E-990E-CE28CEB37B2FQ33321675-574A5A4D-AA8F-4806-892F-1F43D7EDF1F1Q33764446-2D4B3C01-F9EA-4251-9DCC-3A7A7D94114BQ33764528-FE1F1BAC-0763-4965-9BD3-6FC08250EF8BQ33780224-841998FB-B34C-4AC5-8EF8-E640F913D58CQ33797033-281C10AD-F4A9-40F9-B852-DBD5878D0D5DQ34223911-4DA4B953-14D5-43E0-BB67-ECBD088FF3CDQ34963719-C8E7E5A7-AD83-404E-978B-2C2906AC6A02Q35532994-C148C0CF-DBDF-4EDD-8BAC-0AD4FBB06437Q35618042-C8E67D67-94F2-4889-BC04-60536AD50E39Q35796418-43776608-13E1-4DB1-AC00-B8114110E336Q36149154-970B3A4E-4F95-4EBE-9C2B-63B6FC80AE88Q36327657-55548CE1-32ED-4E34-B822-35FC4EB1E0A2Q36540907-1E4EE0EB-5F6E-4EB6-BAA3-5B31E28F379BQ36682636-F0D66644-61B9-45F3-8C91-07BA3F950F2BQ37646590-80801D61-2D7B-4B10-99A2-6DD85C7125E3Q37752222-D081136D-BBBB-492A-B73D-5FEB917579E3Q38391222-9A997AC8-DECE-48B7-9B2D-BF7EEC1B1304Q38407951-13C33F3D-98F6-4F10-BF8D-E00341EB4347Q38527037-9F47752D-3CC0-45F8-87C8-485020A11A89Q38816375-DAAFA3F5-F92E-4483-8FF2-E77F0548AE67Q38942700-2D5C4C59-EEC4-4709-936F-6BC446201A20Q39223911-E10C3E1B-A485-445B-8452-7394C89B10BEQ39397341-96CAC0AC-8358-454E-A32C-5D7B9D61653FQ39425453-C623DA7C-F916-4B3B-A529-D865399C0C4AQ39695079-D0302953-07B2-4423-B102-5D926AAF3690Q40077556-EE74FD81-8127-4067-AAA2-556D845418A5Q40107337-EA13EB34-1BFE-42B0-B77F-C05B20744EF9Q40959238-34C86C9C-165B-437E-97F7-39974FCB91B1Q41095390-3F3CBA69-861D-42B2-8EFB-610D545FE3B6Q41506315-0BB9FCA5-B3B4-4233-AB76-58BF8A89FA3EQ41664534-18096CF5-0D73-463B-BAE5-3D0586317E31Q41672018-F3F7D822-ED5E-438E-ACF5-BA4E445134FCQ42786139-7D0B560C-8EC0-4491-8382-E5D168325509Q42786146-AD627E82-C176-43D7-BCDB-A2407CAAF302
P50
description
researcher
@en
ricercatore
@it
wetenschapper
@nl
հետազոտող
@hy
name
Christophe Bauters
@ast
Christophe Bauters
@en
Christophe Bauters
@es
Christophe Bauters
@nl
type
label
Christophe Bauters
@ast
Christophe Bauters
@en
Christophe Bauters
@es
Christophe Bauters
@nl
prefLabel
Christophe Bauters
@ast
Christophe Bauters
@en
Christophe Bauters
@es
Christophe Bauters
@nl
P214
P106
P21
P214
P31
P496
0000-0001-8268-8467
P7859
viaf-209991353